GSK‐3β regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type IIα

Deregulation of GSK‐3β is strongly implicated in a variety of serious brain conditions, such as Alzheimer disease, bipolar disorder and schizophrenia. To understand how GSK‐3β becomes dysregulated in these conditions, it is important to understand its physiological functions in the central nervous s...

Descripción completa

Detalles Bibliográficos
Autores principales: Amici, Mascia, Lee, Yeseul, Pope, Robert J. P., Bradley, Clarrisa A., Cole, Adam, Collingridge, Graham L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Special Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554790/
https://www.ncbi.nlm.nih.gov/pubmed/32463939
http://dx.doi.org/10.1111/ejn.14841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554790/
https://www.ncbi.nlm.nih.gov/pubmed/32463939
http://dx.doi.org/10.1111/ejn.14841

Ejemplares similares